Deprecated: Return type of Twig\Markup::count() should either be compatible with Countable::count(): int, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in /www/scri2022_179/public/wp-content/plugins/timber-library/vendor/twig/twig/src/Markup.php on line 38
[Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance].
Huber H, Thaler J, Greil R, Gattringer C, Radaszkiewicz T. Onkologie. 1986 Apr,9(2):108-13.
View this publication in the PUBMED databaseImportance of an 85 kDa membrane glycoprotein for a variety of cell-cell interactions.
Schulz TF, Vogetseder W, Mitterer M, Neumayer HP, Myones BL, Stauder R, Greil R, BГ¶ck G, Feichtinger H, Huber H, et al. Mol Immunol. 1988 Nov,25(11):1053-61.
View this publication in the PUBMED databaseExpression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour.
Stauder R, Greil R, Schulz TF, Thaler J, Gattringer C, Radaskiewicz T, Dierich MP, Huber H. Clin Exp Immunol. 1989 Aug,77(2):234-8.
View this publication in the PUBMED databaseImmunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin.
Thaler J, Denz H, Dietze O, Gastl G, Ho AD, Gattringer C, Greil R, Lechleitner M, Huber C, Huber H. Leuk Res. 1989,13(5):377-83.
View this publication in the PUBMED databaseDose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
Heinrich, E; Schally, AV; Buchholz, S; Rick, FG; Halmos, G; Mile, M; Groot, K; Hohla, F; Zarandi, M; Varga, JL; Prostate. 2008; 68(16):1763-1772
View this publication in the PUBMED databaseImproved outcome following reduced-intensity conditioning for second allogeneic stem cell transplantation
Nachbaur, D; Auberger, J; Clausen, J; Lindner, B BONE MARROW TRANSPL. 2009; 43: S285-S286.
Reduced-intensity HLA-haplo-identical stem cell transplantation with post transplantation cyclophosphamide in patients with advanced haematological malignancies
Nachbaur, D; Auberger, J; Muehlmann, R; Kircher, B; Clausen, J BONE MARROW TRANSPL. 2009; 43: S286-S286.
Serum catalase to predict graft-versus-host disease after allogeneic stem cell transplantation
Kircher, B; Schumacher, P; Clausen, J; Auberger, J; Nachbaur, D BONE MARROW TRANSPL. 2009; 43: S118-S118.
A low or high body mass index is not predictive for outcome following allogeneic haematopoietic stem cell transplantation
Auberger, J; Clausen, J; Kircher, B; Gastl, G; Nachbaur, D BONE MARROW TRANSPL. 2009; 43: S373-S374.
Association between antinuclear antibodies and antibodies against cyclic citrullinated peptides in patients from an Austrian rheumatology outpatient clinic._x000D_
Wegscheider, P; Psenak, O; Greil, R; Studnicka-Benke, A; EULAR annual report. 2009; -10th EULAR congress; 10.-13.06.2009; Kopenhagen.